IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,814 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 30,477,080 | $31,017,758 | 1.54% |
| SHENKMAN CAPITAL MANAGEMENT INC | 17,691,000 | $17,931,726 | 1.34% |
| BRAIDWELL LP | 37,509,000 | $37,250,188 | 1.18% |
| III Capital Management | 16,200,000 | $16,068,483 | 0.81% |
| DLD Asset Management, LP | 7,500,000 | $7,471,875 | 0.80% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 34,375,000 | $34,057,674 | 0.73% |
| Worth Venture Partners, LLC | 1,034,000 | $1,029,476 | 0.61% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 40,200,000 | $39,922,620 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,055,000 | $3,041,634 | 0.07% |
| Leucadia National | 7,149,000 | $7,051,572 | 0.06% |